TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 278 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,078 | +108.5% | 199 | +111.7% | 0.00% | – |
| Q2 2023 | $1,476 | -4.7% | 94 | 0.0% | 0.00% | – |
| Q1 2023 | $1,549 | +5.7% | 94 | 0.0% | 0.00% | – |
| Q4 2022 | $1,466 | +46.6% | 94 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 94 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 94 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 94 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 94 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | – | 94 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |